Biotech Archives - Page 790 of 795

1 minute read

Inventiva Announces The Screening Of The First Patient In LEGEND, A Phase IIa Combination Trial With Lanifibranor And Empagliflozin In Patients With NASH And T2D

July 7, 4:01 PM

The Phase IIa Proof-of-Concept study is designed to assess the safety and efficacy of lanifibranor in combination with the SGLT2 inhibitor empagliflozin for the treatment of patients with non-cirrhotic non-alcoholic

IVA

2 minute read

Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader

By Lara Goldstein

July 7, 3:14 PM

Atai Life Sciences N.V.

ARKG

2 minute read

Vertex Announces Letter Of Intent With The pan-Canadian Pharmaceutical Alliance For Public Reimbursement Of TRIKAFTA in Children With Cystic Fibrosis Ages 6 And Older

By Benzinga Newsdesk

July 7, 2:28 PM

Vertex Pharmaceuticals Incorporated (Canada) (NASDAQ:VRTX) today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA), which represents an agreement in principle

VRTX

1 minute read

FDA
News

‘Louisiana confirms first case of monkeypox’ -Nola.com

By Benzinga Newsdesk

July 7, 1:10 PM

https://www.nola.com/news/healthcare_hospitals/article_42100524-fbf9-11ec-bd50-1719af89cf9b.html

AEMD

2 minute read

Elon Musk, You’re Cordially Invited To The Benzinga Cannabis Capital Conference In Chicago, No Need To RSVP, See You There?

By Maureen Meehan

July 7, 11:10 AM

If Tesla (NASDAQ: TSLA) CEO Elon Musk had not been having an ‘excruciating’ year, he might have had the good fortune to attend the very first Benzinga Cannabis Capital Conference in Toronto in April 2018.

TSLA

1 minute read

FDA
News

Six Countries Seek Expansion Of Partial IP Waiver For Covid-19 Vaccines To Drugs And Tests By Year-End

By Benzinga Newsdesk

July 7, 10:38 AM

-Reuters

AZN

1 minute read

Galmed’s Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal Model

By Vandana Singh

July 7, 10:18 AM

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) announced results showing significant effects of Aramchol in a preclinical lung and gastrointestinal (GI) fibrosis model. Treatment…

GLMD

3 minute read

The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

By Vandana Singh

July 7, 10:03 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADVM

1 minute read

FDA
News

Public Health Authority Slovakia Confirms First Case Of Monkeypox

By Benzinga Newsdesk

July 7, 9:56 AM

-Reuters

AEMD

1 minute read

Verve Therapeutics Amends Gene Editing Pact With Beam Therapeutics

By Vandana Singh

July 7, 8:28 AM

Verve Therapeutics Inc (NASDAQ:VERV) entered into an Amended and Restated Collaboration and License Agreement with Beam Therapeutics Inc (NASDAQ:BEAM), which amended…

BEAM